Volume 125, Issue 2 , Pages 461-468.e6, February 2010
Color-coded real-time cellular imaging of lung T-lymphocyte accumulation and focus formation in a mouse asthma model
Article Outline
- Abstract
- Methods
- Mice
- In vitro TH2-cell differentiation cultures
- Ovalbumin sensitization, cell transfer, and ovalbumin inhalation
- Fluorescence imaging of cell accumulation in the lung
- Dexamethasone treatment
- Anti–ICAM-1 and anti–VCAM-1 antibody treatment
- In vivo imaging of lung infiltrating T cells by scanning laser microscopy
- Lung histology and immunohistochemistry
- Statistical analysis
- Results
- Color-coded fluorescence imaging of selective accumulation of ovalbumin-primed CD4 T cells into the lung in an ovalbumin-induced acute-asthma mouse model
- Imaging of ovalbumin-specific OT II–TH2 cell accumulation into the lung and the generation of GFP+ TH2 cell foci in a mouse model of asthma
- Real-time cellular dynamics of TH2-cell accumulation in the lung of living mice in a mouse model of asthma
- Effect of dexamethasone on the accumulation of ovalbumin-primed CD4 T cells in the lung in a mouse model of asthma
- Contribution of adhesion molecules to the generation of TH2-cell foci in the lung in a mouse model of asthma
- Eosinophilic infiltration and GFP+ TH2-cell infiltration into the lung in a mouse model of asthma
- Discussion
- Acknowledgment
- Fig E1.
- Fig E2.
- Fig E3.
- Fig E4.
- Supplementary data
- References
- Reference
- Copyright
Background
A critical role for CD4+TH2 cells in the pathogenesis of acute asthma has been demonstrated in the studies of human asthma as well as of animal models of asthma. TH2-cell migration into the lung is crucial for the initiation of asthma phenotype, but the dynamics of this process are poorly understood because it has been difficult to visualize this process.
Objective
Our aim was to image the cellular dynamics of the migration of TH2 cells into the lung of living animals in a mouse model of asthma and identify the cellular processes required for the initiation of the asthma phenotype.
Methods
We developed a color-coded real-time imaging model of cell migration into the lung using green fluorescent protein (GFP) and red fluorescent protein (RFP) transgenic CD4 T cells.
Results
Selective accumulation of antigen-specific CD4 T cells in the lungs was quantitatively imaged in a mouse model of asthma. The inhibition of accumulation by dexamethasone was imaged. Accumulating GFP+ TH2 cells formed foci in the lungs from 6 to 20 hours after antigen inhalation. This process was also inhibited by the administration of anti–intercellular adhesion molecule 1 or anti–vascular cell adhesion molecule 1 mAbs. Two days after inhalation of antigen, GFP+ TH2 cells were detected in the area of eosinophil infiltration.
Conclusion
Focus formation generated by accumulating antigen-specific TH2 cells in the lung appeared to be a critical process in the initiation of the asthma phenotype. This new model enables the study of in vivo cell biology of airway inflammation and novel drug discovery for lung inflammatory diseases.
Key words: Real-time in vivo cellular imaging, cellular dynamics, TH2 cells, mouse model of asthma,, focus formation, airway inflammation, GFP, ICAM-1, VCAM-1
Abbreviations used: DEX, Dexamethasone, GFP, Green fluorescent protein, H&E, Hematoxylin and eosin, ICAM-1, Intercellular adhesion molecule 1, NIH, National Institutes of Health, RFP, Red fluorescent protein, TCR, T-cell receptor, Tg, Transgenic, VCAM-1, Vascular cell adhesion molecule 1
Lung inflammatory diseases such as asthma are major public health problems that have increased markedly in prevalence in the past 3 decades.1 Asthma is characterized by a chronic inflammatory disease of the lower airways that causes airway hyperresponsiveness to a wide variety of specific and nonspecific stimuli.2, 3 The cardinal features of acute asthma are airway inflammation predominated by eosinophils, hypersecretion of mucus, and airway hyperresponsiveness. A critical role for CD4+ TH2 cells in the pathogenesis of acute asthma has been demonstrated in studies of human asthma as well as in animal models of allergic airway inflammation.4, 5, 6, 7, 8, 9, 10 Previous investigations have studied T-cell migration during allergic reactions by using an adoptive cell transfer system.11, 12, 13 The administration of anti–intercellular adhesion molecule 1 (ICAM-1) or anti–vascular cell adhesion molecule 1 (VCAM-1) antibody resulted in the inhibition of eosinophilic airway inflammation.14 However, the in vivo dynamics of cell migration into the lung during inflammation in living animals is poorly understood because of the lack of an appropriate in vivo cellular imaging model. The use of fluorescent proteins for imaging, which we pioneered, allowed us to monitor cell migration in vivo.15 Green fluorescent protein (GFP) and red fluorescent protein (RFP) were used to label living cells genetically in vivo as well as in vitro16, 17 and served as a powerful tool to monitor the migration of specific lymphocytes in live animals.
We report here a novel in vivo real-time color-coded cellular imaging model to visualize the dynamics of migration of T cells in a mouse model of asthma. We have found that accumulating TH2 cells formed foci in the lungs 6 to 20 hours after allergen inhalation. Focus formation was dependent on ICAM-1 and VCAM-1 and appeared to determine the site of eosinophilic infiltration, indicating that TH2-cell focus formation is a critical process during the initiation of airway inflammation in this animal model.
Methods
Mice
C57BL/6 were purchased from Charles River Laboratories (Wilmington, MA). C57BL/6-transgenic (Tg) (CAG-EGFP)C14-Y01-FM131Osb (GFP Tg, C57BL/6 background) mice expressed an enhanced GFP in all tissue under the control of the β-actin promoter.16 C57BL/6 background RFP Tg mice expressed RFP (DsRed-2) under the control of the chicken β-actin promoter and cytomegalovirus enhancer.17, 18 Ovalbumin-specific T-cell receptor αβ transgenic (OT II Tg) mice19 were maintained under specific pathogen-free conditions. All animal care was carried out in accordance with the National Institutes of Health (NIH) guidelines (NIH assurance no. A3873-01) at AntiCancer, Inc, and the guidelines of Chiba University. All animal experiments were performed at AntiCancer Inc.
In vitro TH2-cell differentiation cultures
Green fluorescent protein Tg x OT II Tg CD44low CD4 T cells (2 × 105) were purified by cell sorting and stimulated with antigenic ovalbumin peptide (Loh 15, 1 μmol/L) and irradiated (30 Gy) syngeneic antigen-presenting cells (1 × 106) in the presence of exogenous IL-4 as described previously.20
Ovalbumin sensitization, cell transfer, and ovalbumin inhalation
The GFP or RFP Tg mice were immunized intraperitoneally with 250 μg ovalbumin (chicken egg albumin from Sigma St Louis, Mo) in 4 mg aluminum hydroxide gel (alum) on days 0 and 7. Splenic CD4 T cells from ovalbumin-sensitized GFP or RFP Tg mice were isolated by magnetic negative selection using a CD4+ T-cell isolation kit (Miltenyi Biotec, Bergish Gladbach, Germany) on day 14, yielding a purity of >98%. These cells (2 × 107 cells) or ovalbumin-specific TH2 cells (5 × 106 cells) were transferred intravenously through the tail vain to 8-week-old C57BL/6 recipient mice. One or 2 days later, the recipient mice inhaled aerosolized ovalbumin in saline (10 mg/mL) for 30 minutes with a supersonic nebulizer (NE-U07; Omron Co, Kyoto, Japan) as described previously.21
Fluorescence imaging of cell accumulation in the lung
The mice were killed by CO2 asphyxiation at various times after ovalbumin inhalation. The lungs were removed, and GFP+ cells that had accumulated in the excised lung were monitored by using an OV100 Small Animal Imaging System (Olympus Corp., Tokyo, Japan).15, 22, 23
Dexamethasone treatment
Splenic CD4 T cells (2 × 107 cells) were transferred intravenously through the tail vein to 8-week-old C57BL/6 recipient mice on day 14. One hour before the airway challenge by ovalbumin inhalation (on day 15), mice were injected intraperitoneally with dexamethasone (0.4, 1, or 4 mg/kg). The mice were exposed to allergen challenges on days 15, and transferred GFP+ CD4 T cells were monitored on day 16. Where indicated, dexamethasone was injected 1 hour before (day 15) or 1 day after ovalbumin inhalation (day 16). Two days after OVA inhalation (day 17), GFP+ CD4 T cells were monitored by using the OV100 Small Animal Imaging System.
Anti–ICAM-1 and anti–VCAM-1 antibody treatment
Ovalbumin-specific TH2 cells (5 × 106 cells) were transferred intravenously through the tail vein of 8-week-old C57BL/6 recipient mice. Twenty-four hours before the airway challenge by ovalbumin inhalation, mice were injected intraperitoneally with 200 μg anti–ICAM-1 (YN1/1.7.4) or anti–VCAM-1 (429) mAbs.14 One day after ovalbumin inhalation, transferred ovalbumin-specific TH2 cells were monitored by using the OV100 Small Animal Imaging System.
In vivo imaging of lung infiltrating T cells by scanning laser microscopy
Control mice and mice given ovalbumin were prepared surgically at various indicated time points after ovalbumin administration for lung imaging. The mice were anesthetized and tracheostomized on the surgical bed and kept at 37°C. The right bronchus was clamped to stop movement during ventilation. The left lung was mechanically ventilated with O2 at the normal respiratory rate to keep the mice alive. The clamped right lung was monitored with the IV100 scanning laser microscope (Olympus Corp., Tokyo, Japan). The IV100 microscope enabled imaging up to 100 μm depth from the surface of the lung. A 488-nm argon laser was used. To create an in vivo video image, images were recorded at 5-second intervals for 40 minutes. A focus was scored when more than 50% of the 2-dimentional area was occupied by the infiltrating GFP+ cells. Crawling (motile) cells in the lung were defined as those that migrated or elongated to more than 50% of their diameter. The NIH Image software program (NIH Image J 1.41) was used for image analysis.
Lung histology and immunohistochemistry
The mice were killed by CO2 asphyxiation at the indicated times after ovalbumin inhalation, and the lungs were infused with 10% (vol/vol) formalin in PBS or 4% (vol/vol) paraformaldehyde for fixation. The lung samples were sectioned, stained with hematoxylin and eosin (H&E), and examined for pathological changes under a light microscope at magnification ×50 or ×200.7 Lung specimens were embedded in Tissue-Tek optimal cutting temperature compound (Sakura Fluelek, Tokyo, Japan), frozen in liquid nitrogen, and cut with a cryostat into 6-μm-thick sections. Endogenous peroxidase activity as well as nonspecific protein binding was sequentially blocked by using 0.6% hydrogen peroxide and Biotin-Blocking System reagent (DAKO, Glostrup, Denmark), respectively. The sections were incubated with hamster anti-GFP mAb (AdD Serotec, Oxford, UK) at 10 μg/mL overnight at 4°C and then were washed in TRIS-buffered saline with Tween. Bound antibody was detected by sequential incubation with biotinylated rabbit antihamster IgG and streptavidin–horseradish peroxidase followed by 3,3-diaminobenzidine (DAKOCytomation). The slides were then washed and counterstained with hematoxylin.
Statistical analysis
Experimental data were expressed as the means + SDs. The significance between 2 groups was determined by the 2-tailed Student t test.
Results
Color-coded fluorescence imaging of selective accumulation of ovalbumin-primed CD4 T cells into the lung in an ovalbumin-induced acute-asthma mouse model
To examine the CD4 T-cell behavior in the lung of living mice in a mouse model of asthma, we developed a color-coded imaging model using GFP or RFP Tg CD4 T cells (Fig 1, A). Immediately after cell transfer, numerous transferred cells temporally and nonspecifically accumulated in the lung capillaries (data not shown). One day later, some of the cells remained in the lung with no significant difference between sensitized GFP+ and non-sensitized RFP+ cells (Fig 1, B, left; before inhalation). One day after ovalbumin inhalation, the number of GFP+ CD4 T cells from ovalbumin-immunized mice increased significantly, and some of them formed foci (Fig 1, B, center; after inhalation). In contrast, the number of RFP+ CD4 T cells from nonimmunized mice did not increase in the lung (Fig 1, B and C). These results indicate that CD4 T-cell migration into the lung after ovalbumin inhalation is ovalbumin priming–dependent. When we used the opposite color-coded immunization pattern, only the ovalbumin-primed RFP+ CD4 T cells accumulated in the lung, not the nonprimed GFP+ CD4 T cells (see this article's Fig E1, A and B, in the Online Repository at www.jacionline.org). These results indicate that the difference in accumulation is not fluorescent protein–dependent. Furthermore, we examined the migration of naive antigen-specific CD4 T cells in the lung. Ovalbumin-specific CD4 T cells were prepared from nonimmunized mice derived by crossing GFP Tg mice with OT II Tg mice, which have ovalbumin-specific, MHC class II–restricted αβ T-cell receptors.19 Most of the CD4 T cells in the OT II Tg mice are ovalbumin-specific. Ovalbumin-specific CD4 T cells were transferred intravenously into normal C57BL/6 mice 24 hours before airway challenge with aerosolized ovalbumin. Twenty-four hrs after ovalbumin inhalation, GFP+ cells in the excised lungs were monitored by fluorescence imaging. The number of GFP+ OT II Tg–CD4 T cells did not increase in the lung (see this article's Fig E2 in the Online Repository at www.jacionline.org). These results indicate that even antigen-specific CD4 T cells do not accumulate in the lung after allergen challenge if the cells are not primed.

Fig 1.
Color-coded fluorescence imaging of ovalbumin (OVA)-primed CD4 T-cell accumulation in the lung in the OVA-induced acute asthma model. A, A schematic overview of the study protocol for the induction of asthma. GFP Tg mice were sensitized with OVA on days 0 and 7. Splenic CD4 T cells from OVA-sensitized GFP Tg and nonsensitized RFP Tg mice were purified and injected into normal C57BL/6 mice on day 14. The recipient mice were exposed to airway challenge with aerosolized OVA on day 15. B, Color-coded images of GFP+ and RFP+ CD4 T cells. GFP+ and RFP+ CD4 T cells in the excised lung were monitored before OVA inhalation on day 15 and 24 hours after OVA inhalation on day 16 by using the OV100 Small Animal Mouse Imaging System. Bar, 100 μm. C, Summary of the accumulation of fluorescent cells. Data are from 15 fields from 3 mice with SD. Open bar, GFP; closed bar, RFP. ∗P < .001 by the Student's t test.
Imaging of ovalbumin-specific OT II–TH2 cell accumulation into the lung and the generation of GFP+ TH2 cell foci in a mouse model of asthma
To investigate the dynamics of accumulating antigen-specific effector T cells in the lung of living mice in a mouse model of asthma, ovalbumin-specific TH2 cells (OT II–Tg–TH2) were prepared in vitro from naive CD4 T cells obtained from GFP+ OT II Tg mice. Ovalbumin-specific OT II–Tg–TH2 cells expressing GFP were transferred intravenously into normal C57BL/6 mice. Immediately after cell transfer, numerous transferred cells temporally and nonspecifically accumulated in the lung capillaries (data not shown). Twenty-four hours after cell transfer, the recipient mice were exposed to allergen challenge with aerosolized ovalbumin. GFP+ OT II–TH2 cells were imaged under fluorescence microscopy at various time points as long as 24 hours after ovalbumin inhalation by excising the lung (Fig 2, A). The accumulation of GFP+ OT II–TH2 cells in the lung was detected beginning 6 hours after allergen inhalation. The maximum number of OT II–TH2 cells accumulated between 18 and 24 hours. GFP+ OT II–TH2 cells formed small foci 6 hours after ovalbumin inhalation (Fig 2, A). The number of foci increased, and their mean size also increased at 12 hours. The number of foci in the lungs further increased (18 hours). Nonfocal GFP+ cells also greatly increased in the lung. At 18 hours or later, the border of the foci became diffuse, and many foci appeared to be fused. For color-coded imaging of the migration of nonprimed CD4 T cells around the OT II–TH2-cell foci, GFP+ OT II–TH2 cells and splenic CD4 T cells from nonsensitized RFP Tg mice were purified and intravenously transferred together into normal C57BL/6 mice 24 hours before airway challenge with aerosolized ovalbumin. Twenty-four hours after ovalbumin inhalation, GFP+ and RFP+ cells in the excised lungs were monitored by fluorescence imaging. The number of RFP+ CD4 T cells from nonimmunized mice did not increase around the OT II–TH2 cell foci (see this article's Fig E3 in the Online Repository at www.jacionline.org). These results indicate that unprimed CD4 T cells do not accumulate in the foci formed by antigen-specific TH2 cells. We have performed time course experiments. Most antigen-specific TH2 cells accumulated in the lung within 24 hours after antigen inhalation. The accumulated cells that formed foci remained as long as 72 hours after antigen inhalation (data not shown).

Fig 2.
Imaging of ovalbumin-specific OT II–TH2-cell accumulation in the lung and the generation of GFP+ TH2-cell foci after ovalbumin inhalation. GFP+ OT II–TH2 cells, differentiated in vitro from naive CD4 T cells from GFP+ OT II Tg mice, were intravenously transferred into C57BL/6 mice. Two days later, the recipient mice were administered ovalbumin by inhalation. The mice were subjected to imaging at indicated time points after ovalbumin inhalation. GFP+ TH2 cells were imaged by using the OV100 Small Animal Imaging System (A) or the IV100 scanning laser imaging system (B). Red asterisks indicate the site of focus formation. Bar, 300 μm (A) and 100 μm (B). The results are representative of 5 (A) and 3 (B) experiments.
Real-time cellular dynamics of TH2-cell accumulation in the lung of living mice in a mouse model of asthma
Real-time cellular dynamics of antigen-specific TH2-cell accumulation into the lung was then imaged in living mice at the cellular level by using scanning laser fluorescence microscopy. To image this process, antigen-specific TH2 cells generated in vitro from naive CD4 T cells of GFP+ OT II Tg mice were transferred intravenously into normal C57BL/6 mice. The recipient mice were administered ovalbumin by inhalation. They were then anesthetized and tracheostomized, and the lung was exposed microsurgically at various time points after ovalbumin inhalation. First, to assess any changes in blood flow rates in the clamped right lung and ventilated left lung, fluorescent microspheres were infused before and after clamping and ventilation. The lungs were then monitored by fluorescence microscopy (see this article's Fig E4 in the Online Repository at www.jacionline.org). Thirty minutes after clamping and ventilation, blood flow rates in both lungs were comparable. The relative blood flow was still kept at more than 80% of that before clamping and ventilation. Thus, the relative blood flow rates in the clamped lung appeared not to be changed in this experimental system.
The clamped right lungs were then imaged with the IV100 scanning laser microscope. Before ovalbumin inhalation, no foci were observed in the lung (Fig 2, B; Table I; see this article's Video E1 in the Online Repository at www.jacionline.org). The rate of rolling GFP+ TH2 cells in the field was 14.7 + 1.5 cells/mm2/30 min. Some of the rolling cells attached and accumulated in the field (7.0 + 1.5 cells/mm2/30 min), and a similar amount of the TH2 cells egressed from the field (7.0 + 1.0 cells/mm2/30 min). These results suggest that the allergen-specific effector T cells were rolling in the lung vessels, and some were migrating into and accumulating in the lung, whereas some were migrating out of the lung. At time 0, the ratio of cells that accumulated and egressed from the field was equivalent, and the total cell number in the lung appeared to be maintained at a constant level. Only 10% of the TH2 cells in the lung were crawling in this stable state (see this article's Video E2 in the Online Repository at www.jacionline.org). Six hours after ovalbumin inhalation, small foci were observed (Fig 2, B, red asterisks). By 6 hours, the number of rolling TH2 cells greatly increased compared with the stable state (33.3 + 3.1 vs 14.7+1.5 cells/mm2/30 min; Table I). GFP+ TH2-cell accumulation in the lung also increased (15.3 + 1.5 cells/mm2/30 min; Table I; see this article's Video E3 in the Online Repository at www.jacionline.org). The degree of GFP+ TH2-cell egress from the field was similar to that observed in the stable state. By 6 hours, the ratio of crawling cells was observed to increase (30.5% from 10.0%). These observations suggest that the allergen-induced migration and accumulation of TH2 cells into the lung began to be upregulated by 6 hours after ovalbumin inhalation. The formation of foci was also observed approximately 6 hours after ovalbumin inhalation. Twelve hours after ovalbumin inhalation, the foci became larger, and the number of TH2 cells rolling in the field further increased (44.7 + 4.5 cells/mm2/30 min; Table I; see this article's Video E4 in the Online Repository at www.jacionline.org). TH2-cell accumulation in the lung also further increased (24.3 + 2.5 cells/mm2/30 min). However, the degree of TH2-cell egress from the field did not obviously change compared with that observed in the stable state (8.3 + 1.6 vs 7.0 + 1.0). At 12 hours after ovalbumin inhalation, 90% of the TH2 cells accumulating in the field were crawling (see this article's Video E5 in the Online Repository at www.jacionline.org). Thus, allergen-induced migration and accumulation of TH2 cells into the lung appeared to be highly upregulated at approximately 12 hours after ovalbumin inhalation. At 21 hours after ovalbumin inhalation, nonfocal TH2 cells greatly increased (868.7 + 296.5 cells/mm2/30 min at 21 hours). More than 95% of the accumulating cells were crawling at this time point. However, at 21 hours, TH2 cells rolling into the field were apparently reduced (2.7 + 0.6 cells/mm2/30 min; Table I; see this article's Video E6 in the Online Repository at www.jacionline.org). Therefore, the allergen-induced migration and accumulation of TH2 cells into the lung reached maximum levels by 21 hours after ovalbumin inhalation. Between 6 and 12 hours after ovalbumin inhalation, the migrating TH2 cells predominantly formed foci. Later, at 12 to 21 hours after ovalbumin inhalation, the TH2 cells were observed to accumulate throughout the lung rather than form foci.
Table I. Summary of nonfocal OT II–TH2 cell accumulation in the lung after ovalbumin inhalation
| After ovalbumin inhalation | 0 h | 6 h | 12 h | 21 h |
|---|---|---|---|---|
| Cell number in nonfocal area (cells/mm2) | 57.7 ± 4.5 | 134.3 ± 16.9 | 226.0 ± 25.1 | 868.7 ± 296.5 |
| Cells rolling in the blood vessel (cells/mm2/30 min) | 14.7 ± 1.5 | 33.3 ± 3.1 | 44.7 ± 4.5 | 2.7 ± 0.6 |
| Cells accumulated in the field (cells/mm2/30 min) | 7.0 ± 1.5 | 15.3 ± 1.5 | 24.3 ± 2.5 | 1.3 ± 0.6 |
| Cells egressed from the field (cells/mm2/30 min) | 7.0 ± 1.0 | 8.0 ± 1.5 | 8.3 ± 1.6 | 0.7 ± 0.6 |
| Cells crawling in the field (%) | 10.0 | 30.5 | 90.0 | 96.0 |
Effect of dexamethasone on the accumulation of ovalbumin-primed CD4 T cells in the lung in a mouse model of asthma
The color-coded imaging system was then used to determine the effect of dexamethasone, a potent drug that attenuates allergic reactions, on the accumulation of allergen-primed CD4 T cells in the lung. Dexamethasone (0.4, 1, or 4 mg/kg) was administered intraperitoneally 1 hour before ovalbumin inhalation. GFP+ CD4 T cells were monitored by fluorescence imaging 24 hours after ovalbumin inhalation. A marked dexamethasone dose-dependent decrease in the number of infiltrated CD4 T cells was observed in the excised lung (Fig 3, A and B). These results suggest that the efficacy of dexamethasone in inhibiting the development of ovalbumin-induced airway inflammation was, at least in part, a result of the inhibition of CD4 T-cell accumulation into the lung. Dexamethasone was then administered intraperitoneally after ovalbumin inhalation (on day 16), and GFP+ CD4 T cells were monitored by fluorescence imaging 1 day later. The extent of infiltration of GFP+ CD4 T cells was again observed to decrease significantly (Fig 3, C and D). These results indicate that the infiltration of CD4 T cells was reduced if dexamethasone was administered even after the onset of airway inflammation.

Fig 3.
Effects of dexamethasone, anti–ICAM-1, and anti–VCAM-1 treatment on CD4 T-cell accumulation in the lung after ovalbumin (OVA) inhalation. A, Allergic airway inflammation was induced as in Fig 1, A. Three different doses of dexamethasone (DEX) were injected intraperitoneally 1 hour before OVA inhalation. Twenty-four hours after inhalation (day 16), GFP+ CD4 T cells were monitored by using the OV100 Small Animal Imaging System. Bar, 100 μm. B, Summary of the accumulation of fluorescent cells of A. Data are from 15 fields from 3 mice with SD. P < .001 by the Student's t test. C, Dexamethasone was injected intraperitoneally 1 hour before or 1 day after OVA inhalation. Two days after inhalation, GFP+ CD4 T cells were monitored in the excised lung by using the OV100 Small Animal Imaging System. Bar, 100 μm. D, Summary of the accumulation of fluorescent cells of C. The data are from 15 fields from 3 mice with SD. P < .001 by the Student's t test. E, Allergic airway inflammation was induced as in Fig 2, A. Anti–ICAM-1 or anti–VCAM-1 mAb was injected intraperitoneally 24 hours before OVA inhalation. Twenty-four hours after OVA inhalation, GFP+ OT II–TH2 cells were monitored. Bar, 100 μm. F, Summary of the generation of TH2-cell foci in E. Data are from 12 fields from 3 mice with SD. P < .002, P < .001 by the Student's t test.
Contribution of adhesion molecules to the generation of TH2-cell foci in the lung in a mouse model of asthma
We next assessed the contribution of adhesion molecules to the generation of TH2-cell foci in the lung in a mouse model of asthma. The blockage of ICAM-1 and VCAM-1 by antibodies to these molecules is known to inhibit airway inflammation.14 To test the role of ICAM-1 and VCAM-1 in our model, GFP+ OT II–TH2 cells were transferred intravenously into normal C57BL/6 mice. One day before ovalbumin inhalation, mice were injected intraperitoneally with 200 μg anti–ICAM-1 (YN1/1.7.4) or anti–VCAM-1 (429) mAbs. One day after ovalbumin inhalation, transferred ovalbumin-specific GFP+ TH2 cells were monitored by using fluorescence imaging. The generation of GFP+ TH2-cell foci in the lung was substantially inhibited by treatment with anti–ICAM-1 and anti–VCAM-1 mAbs (Fig 3, E and F). Our model demonstrates that ICAM-1 and VCAM-1 play an essential role in focus formation by the control of TH2-cell migration in the lung. Thus, TH2 focus formation appears to be critical in the development of allergic airway inflammation in this animal model.
Eosinophilic infiltration and GFP+ TH2-cell infiltration into the lung in a mouse model of asthma
Previous studies in animal models suggest a TH2 paradigm for allergic diseases, with an increased activation of TH2 cells that produce TH2 cytokines, thereby resulting in the recruitment and activation of eosinophils. Marked eosinophilic infiltration is characteristic 2 or 3 days after allergen challenge in animal models of allergic airway inflammation.7, 9, 10 The foci formed by TH2 cells observed in the current study and accumulation of eosinophils may be coincidental because our results showed that antigen-specific TH2 cells accumulated and formed foci in the lung after allergen inhalation. GFP+ OT I–TH2 cells were intravenously transferred into C57BL/6 mice, and 2 days later, the recipient mice were exposed to ovalbumin. Typical peribronchiolar and perivascular infiltration and focus formation by eosinophils were observed 48 hours after ovalbumin inhalation (Fig 4, A). The infiltrated OT II–TH2 cells were monitored by immunohistochemistry analysis with an anti-GFP antibody. We observed GFP+ transferred TH2 cells in the region of subsequent eosinophilic infiltration (Fig 4, B). These results, in conjunction with the results of our time course experiments (Fig 2), indicate that antigen-specific TH2 cells accumulate and form foci in the lung before the marked infiltration of eosinophils and thus regulate the initiation of inflammatory processes in this animal model.

Fig 4.
Eosinophilic infiltration and GFP+ TH2-cell infiltration into the lung in a mouse model of asthma. A, The lung specimens were fixed at indicated time point after ovalbumin inhalation and stained with H&E. A representative H&E staining pattern in each group is shown. Magnification ×200. B, Representative immunohistochemical staining for GFP is shown. Magnification ×200. Arrows indicate some of the representative GFP-positive cells. The results are representative of 3 experiments.
Discussion
The behavior of T cells during airway inflammation in mouse models of asthma has been investigated by using flow cytometry and immunohistochemistry.24, 25, 26, 27, 28 These studies showed that T cells migrate into the lung after allergen challenge, but the studies did not address how and when they migrate into the lung or whether only antigen-specific effector T cells migrate into the lung. Several investigators performed lung imaging in a serial but static manner. Hutchison et al29 have used serial tissue sectioning to describe the time course of proliferating CD4 T cells in the lung and its draining lymph nodes. Bhattacharya's group30, 31, 32 imaged whole excised lungs to study signaling by lung resident cells. Until now, the in vivo dynamics of cell invasion of the lung during inflammation in living animals has been poorly understood because it has been difficult to arrest motion in the lung as a result of the beating heart or movement during respiration. Our novel imaging model has overcome these problems and has demonstrated, for the first time, the dynamics of migration of allergen-specific TH2 cells into the lung after allergen inhalation in living animals at the cellular level using the adoptive transfer of GFP+ T cells.
With this novel imaging model, several important findings are demonstrated. We have shown for the first time TH2-cell focus formation in the lung, a cellular immunologic event occurring during the initiation of airway inflammation (Fig 2). In addition, we demonstrate that unprimed CD4 T cells and naive antigen-specific CD4 T cells did not accumulate around the foci (Fig 1; Fig E1, Fig E2, Fig E3), indicating that the molecules specifically expressed on activated effector TH2 cells play an important role in migration and focus formation. Moreover, TH2-cell focus formation occurred before eosinophilic infiltration and thus may determine the eosinophilic inflammatory site (Figs 2 and 4). Focus formation was inhibited by the administration of anti–ICAM-1 and anti–VCAM-1 antibodies (Fig 3, E and F), both of which are able to block the induction of eosinophilic airway inflammation, indicating that focus formation is a critical process during the induction of the asthma phenotype.
Several groups have shown time-lapse microscopy of GFP-labeled and/or RFP-labeled cancer cells in live mice. Hoffman's group22, 23 has demonstrated in vivo imaging of intracapillary and intralymphatic cancer cell trafficking behavior. Condeelis' group33 has used in vivo imaging to determine molecular mechanisms of cancer metastasis.
Many groups have reported in vivo imaging of lymphoid tissues such as lymph nodes, spleen, and bone marrow to visualize antigen presentation and T-cell migration.34, 35, 36, 37, 38, 39, 40, 41 To visualize the cells in vivo, they must be labeled by appropriate dyes or express fluorescent proteins. In most of the reports of in vivo imaging of lymphoid tissues, T cells were labeled by using appropriate dyes and transferred into recipient mice, although a possible difference in the migration behavior of the cells that were labeled by dyes has been suggested.42 In our study, we prepared ovalbumin-specific TH2 cells expressing GFP from GFP Tg mice16 and transferred the cells intravenously into normal recipient mice. Another technical issue could be the difference in the migration between antigen-specific cells that were injected into the mice before imaging and antigen-specific T cells that were resident in the imaged mice. In the near future, the behavior of antigen-specific TH2 cells that were resident in the imaged mice will be investigated.
This model allows investigators to monitor the migration of inflammatory lymphocytes into the lung in a real-time manner in live animals and thus provides a new strategy to study the in vivo cell biology of inflammatory lung diseases such as asthma. This method can be also applied to various bacteria-induced and virus-induced inflammatory lung diseases, including tuberculosis and influenza virus–induced pneumonia, and to screen for more effective drugs for these respiratory diseases.
We are grateful to Drs Tatsuo kinashi, Takashi Saito, Larry Samelson, and Ronald Germain for the valuable suggestions during manuscript preparation. We also thank Mr Jose Reynoso for help with the animal studies.
Fig E1.

Color -coded fluorescence imaging of CD4 T-cell infiltration into the lung during ovalbumin (OVA)-induced allergic asthma. A, Color-coded images of CD4 T cells with the opposite color to the experiment shown in Fig 1, B. Splenic CD4 T cells from OVA-primed RFP Tg and nonprimed GFP Tg mice were injected into normal recipient mice. GFP+ and RFP+ CD4 T cells were monitored in the excised lung as in Fig 1, B. Bar, 100 μm. B, Summary of the accumulation of fluorescent cells of A. Data are from 15 fields from 3 mice with SD. Open bar, GFP; closed bar, RFP. P < .001 by the Student's t test.
Fig E2.

Fluorescence imaging of naive OT II–CD4 T and CD4 T cells in the lung. A, Images of naive OT II–CD4 T and CD4 T cells. Unprimed GFP+ OT II–CD4 Tand CD4 T cells were monitored in the lung before ovalbumin inhalation and 24 hours after ovalbumin inhalation by using the OV100 Small Animal Mouse Imaging System. Bar, 150 μm. B, Summary of the accumulation of fluorescent cells of A. Data are from 15 fields from 3 mice with SD. Open bar, OT II–CD4 T cells; closed bar, CD4 T cells.
Fig E3.

Color -coded fluorescence imaging of OT II–TH2 cells and CD4 T cells in the lung. Primed GFP+ OT II–TH2 cells and RFP+ CD4 T cells from nonprimed RFP Tg mice were monitored before ovalbumin inhalation and 24 hours after ovalbumin inhalation by using the OV100 Small Animal Mouse Imaging System. Bar, 150 μm. The results are representative of 3 experiments.
Fig E4.

Measurement of blood flow in the clamped right lung and the ventilated left lung. A, Assessment of blood flow using fluorescent microspheres. Yellow-green fluorescent microspheres (10 μm, Invitrogen) were infused before ventilation and red fluorescent microspheres (10 μm, Invitrogen) infused 30 minutes after ventilation. The excised lungs were assessed by using the OV100 Small Animal Mouse Imaging System. Bar, 150 μm. B, Summary of the number of fluorescent microspheres. Data are from 9 fields from 3 mice with SD. Open bar, left lung; closed bar, right lung NS, not significant.
Supplementary data
Video E1-E6 Dynamic real time cellular imaging of ovalbumin-specific GFP+ OT II–TH2 cell migration into the lung after ovalbumin inhalation in living mice. Ovalbumin-specific GFP+ TH2 cell migration and accumulation in the lung before ovalbumin inhalation (Videos E1 and E2 [high magnification]) and after ovalbumin inhalation: 6 hours (Video E3), 12 hours (Videos E4 and E5 [high magnification]), and 21 hours (Video E6). Individual cells were imaged every 5 seconds. Videos are at ×225 real-time.
References
- . The asthma epidemic. N Engl J Med. 2006;355:2226–2235
- . Asthma. N Engl J Med. 1992;327:1928–1937
- . Asthma. N Engl J Med. 2001;344:350–362
- . IL-5-induced airway eosinophilia—the key to asthma?. Immunol Rev. 2001;179:182–191
- . Mouse models of allergic airway disease. Adv Immunol. 2001;77:263–295
- . New insights into the pathogenesis of asthma. J Clin Invest. 2003;111:291–297
- src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation. J Clin Invest. 2003;111:109–119
- . Interleukin-13 in asthma pathogenesis. Immunol Rev. 2004;202:175–190
- . Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22:789–815
- . The regulation of allergy and asthma. Immunol Rev. 2006;212:238–255
- . Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med. 1997;186:1737–1747
- . Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest. 1999;103:175–183
- Dynamics of antigen-specific helper T cells at the initiation of airway eosinophilic inflammation. Eur J Immunol. 2001;31:2669–2679
- . Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med. 1994;179:1145–1154
- . The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer. 2005;5:796–806
- . Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997;407:313–319
- Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis. 2004;40:241–246
- . A transgenic red fluorescent protein-expressing nude mouse for color-coded imaging of the tumor microenvironment. J Cell Biochem. 2009;106:279–284
- . Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol. 1998;76:34–40
- Impaired GATA3-dependent chromatin remodeling and Th2 cell differentiation leading to attenuated allergic airway inflammation in aging mice. J Immunol. 2006;176:2546–2554
- Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyperresponsiveness. J Allergy Clin Immunol. 2008;122:512–520
- Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system. Cancer Res. 2006;66:4208–4214
- . Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res. 2007;67:8223–8228
- . CD4 + T cells that enter the draining lymph nodes after antigen injection participate in the primary response and become central-memory cells. J Exp Med. 2006;203:1045–1054
- . Memory T cell recruitment to the lung airways. Curr Opin Immunol. 2006;18:357–362
- . Cutting edge: Th2 cell trafficking into the allergic lung is dependent on chemoattractant receptor signaling. J Immunol. 2002;169:651–655
- . Regulation of allergic airway inflammation by class I-restricted allergen presentation and CD8 T-cell infiltration. J Allergy Clin Immunol. 2007;119:226–234
- Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, alpha4beta1 integrin/VCAM-1, and LFA-1 adhesion pathways. J Exp Med. 2003;197:1255–1267
- An investigation of the impact of the location and timing of antigen-specific T cell division on airways inflammation. Clin Exp Immunol. 2009;155:107–116
- . Lung surfactant secretion by interalveolar Ca2+ signaling. Am J Physiol Lung Cell Mol Physiol. 2006;291:L596–L601
- . Real-time lung microscopy. J Appl Physiol. 2007;102:1255–1264
- Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res. 2007;67:8223–8228
- Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. Cancer Res. 2007;67:3505–3511
- . Imaging the single cell dynamics of CD4 + T cell activation by dendritic cells in lymph nodes. J Exp Med. 2004;200:847–856
- . Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science. 2002;296:1869–1873
- Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity. 2006;25:989–1001
- . Dynamics of CD8 + T cell priming by dendritic cells in intact lymph nodes. Nat Immunol. 2003;4:579–585
- . T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature. 2004;427:154–159
- Dynamic imaging of chemokine-dependent CD8 + T cell help for CD8 + T cell responses. Nat Immunol. 2007;8:921–930
- In vivo imaging of germinal centres reveals a dynamic open structure. Nature. 2007;446:83–87
- Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells. Nat Immunol. 2005;6:1029–1037
- . Dynamic imaging of the immune system: progress, pitfalls and promise. Nat Rev Immunol. 2006;6:497–507
Reference
Supported in part by the Global Center of Excellence (COE) Program (Global Center for Education and Research in Immune System Regulation and Treatment), Monbukagakusho (MEXT), Japan, and grants from the Ministry of Education, Culture, Sports, Science and Technology (Japan).
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(09)01404-3
doi:10.1016/j.jaci.2009.09.016
© 2010 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 125, Issue 2 , Pages 461-468.e6, February 2010

